Want to see OKUR full AI Analyst Report?
OnKure Therapeutics (OKUR) Income Statement
OnKure Therapeutics Income Statement
Last quarter (Q2 2026), OnKure Therapeutics's total revenue was $0.00. In Q2, OnKure Therapeutics's net income was $-15.35M. See OnKure Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -830.00K | $ 0.00 | $ 0.00 | $ 0.00 | $ -50.00K | |
| $ 62.12M | $ 54.39M | $ 36.93M | $ 29.77M | $ 39.77M | |
| Depreciation and Amortization | $ 830.00K | $ 662.00K | $ 560.00K | $ 387.00K | $ 50.00K |
| $ -58.69M | $ -51.71M | $ -34.75M | $ -29.13M | $ -39.72M | |
| $ -62.95M | $ -54.39M | $ -36.93M | $ -29.77M | $ -39.82M | |
| $ 3.43M | $ 1.71M | $ 1.62M | $ 254.00K | $ 48.00K | |
| $ -59.52M | $ -52.67M | $ -35.31M | $ -29.51M | $ -39.77M | |
| $ -59.52M | $ -52.67M | $ -35.31M | $ -29.51M | $ -39.77M | |
| Per Share Metrics | |||||
| Basic EPS | $ -4.40 | $ -3.95 | $ -2.65 | $ -2.21 | $ -21.92 |
| Diluted EPS | $ -4.40 | $ -3.95 | $ -2.65 | $ -2.21 | $ -21.92 |
| Weighted Average Shares Outstanding | 13.52M | 13.34M | 13.34M | 13.34M | 1.81M |
| Weighted Average Shares Outstanding (Diluted) | 13.52M | 13.34M | 13.34M | 13.34M | 1.81M |
Currency in USD